Judge kills Actavis' plan to 'hard switch' Alzheimer's drug, refuses to stay order pending appeal
Actavis cannot implement a strategy known as a "hard switch" to drive Alzheimer's patients away from a drug about to face generic competition, a federal judge has ruled, rejecting the drug...To view the full article, register now.
Already a subscriber? Click here to view full article